Jenna Bergerson

2.1k total citations
17 papers, 162 citations indexed

About

Jenna Bergerson is a scholar working on Immunology, Infectious Diseases and Oncology. According to data from OpenAlex, Jenna Bergerson has authored 17 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 3 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Jenna Bergerson's work include Immunodeficiency and Autoimmune Disorders (9 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (4 papers). Jenna Bergerson is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (9 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (4 papers). Jenna Bergerson collaborates with scholars based in United States, Australia and India. Jenna Bergerson's co-authors include Alexandra F. Freeman, Sergio D. Rosenzweig, Stuart E. Turvey, Cristiane N. Santos, Manisha Madkaikar, Priyanka Kambli, Maya Gupta, Jahnavi Aluri, Mukesh Desai and Steven M. Holland and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Hepatology.

In The Last Decade

Jenna Bergerson

14 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenna Bergerson United States 8 106 40 28 23 21 17 162
Tiziana Lorenzini Italy 5 73 0.7× 33 0.8× 19 0.7× 20 0.9× 15 0.7× 9 113
Kay Tanita Japan 7 101 1.0× 44 1.1× 11 0.4× 22 1.0× 22 1.0× 13 141
Maja Klaudel‐Dreszler Poland 7 66 0.6× 42 1.1× 13 0.5× 23 1.0× 13 0.6× 24 123
Reem Mohammed Saudi Arabia 7 85 0.8× 46 1.1× 18 0.6× 17 0.7× 10 0.5× 14 137
Bijun Sun China 9 99 0.9× 40 1.0× 31 1.1× 43 1.9× 23 1.1× 25 188
Lisa Forbes Satter United States 7 102 1.0× 43 1.1× 13 0.5× 23 1.0× 23 1.1× 16 164
Valentina Strohmeier Germany 7 108 1.0× 26 0.7× 12 0.4× 21 0.9× 31 1.5× 9 172
María Isabel Gaillard Argentina 8 155 1.5× 48 1.2× 14 0.5× 33 1.4× 31 1.5× 13 205
Sabrina Weeks United States 2 69 0.7× 32 0.8× 31 1.1× 13 0.6× 16 0.8× 2 122
João Farela Neves Portugal 9 131 1.2× 44 1.1× 27 1.0× 23 1.0× 36 1.7× 24 222

Countries citing papers authored by Jenna Bergerson

Since Specialization
Citations

This map shows the geographic impact of Jenna Bergerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenna Bergerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenna Bergerson more than expected).

Fields of papers citing papers by Jenna Bergerson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenna Bergerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenna Bergerson. The network helps show where Jenna Bergerson may publish in the future.

Co-authorship network of co-authors of Jenna Bergerson

This figure shows the co-authorship network connecting the top 25 collaborators of Jenna Bergerson. A scholar is included among the top collaborators of Jenna Bergerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenna Bergerson. Jenna Bergerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ye, Peiying, Jenna Bergerson, Isaac Brownell, et al.. (2025). Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor Signaling. New England Journal of Medicine. 393(5). 469–478.
2.
Hercun, Julian, Anusha Vittal, Jenna Bergerson, et al.. (2024). Development of hepatic fibrosis in common variable immunodeficiency‐related porto‐sinusoidal vascular disorder. Alimentary Pharmacology & Therapeutics. 60(7). 888–896. 1 indexed citations
3.
Fuss, Ivan J., Jenna Bergerson, Jacqueline Laurin, et al.. (2024). Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study. Alimentary Pharmacology & Therapeutics. 59(12). 1527–1538. 2 indexed citations
4.
Bergerson, Jenna, et al.. (2024). JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity. Journal of Allergy and Clinical Immunology. 155(2). 357–367. 21 indexed citations
5.
Mohsin, Noreen, Jia Yan, Paul Nghiem, et al.. (2024). Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma. JAMA Dermatology. 160(2). 172–172. 6 indexed citations
6.
Sayed, Samir, Ceire Hay, Erica G. Schmitt, et al.. (2024). Amplified STAT3 increases expression of the CD39 ectoenzyme and impairs function of CD8+ T cells.. The Journal of Immunology. 212(1_Supplement). 0800_6275–0800_6275.
7.
Yakov, Gil Ben, Devika Kapuria, David E. Kleiner, et al.. (2022). Tip of the iceberg: A comprehensive review of liver disease in Inborn errors of immunity. Hepatology. 76(6). 1845–1861. 7 indexed citations
8.
Nghiem, Paul, Jenna Bergerson, Morgan Similuk, et al.. (2022). Early-Onset Merkel Cell Carcinoma is Associated with Germline Defects in DNA Repair Genes and a Rare Immunodeficiency. Journal of Investigative Dermatology. 142(10). 2839–2839. 1 indexed citations
9.
James, Alyssa, Amanda Urban, Jason Raasch, et al.. (2022). Treatment of STAT3-deficient hyper–immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation. The Journal of Allergy and Clinical Immunology In Practice. 10(5). 1367–1370.e1. 13 indexed citations
10.
Santos, Cristiane N., Christopher Koh, Keith Sacco, et al.. (2021). Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication. Journal of Allergy and Clinical Immunology. 149(1). 400–409.e3. 11 indexed citations
11.
Ferré, Elise M. N., Monica M. Schmitt, Sebastian Ochoa, et al.. (2021). SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients. Frontiers in Immunology. 12. 720205–720205. 13 indexed citations
12.
Khanolkar, Aaruni, Guorong Liu, Bridget Simpson, et al.. (2020). A case of aberrant CD8 T cell–restricted IL-7 signaling with a Janus kinase 3 defect–associated atypical severe combined immunodeficiency. Immunologic Research. 68(1). 13–27. 2 indexed citations
13.
Bergerson, Jenna & Alexandra F. Freeman. (2018). An Update on Syndromes with a Hyper-IgE Phenotype. Immunology and Allergy Clinics of North America. 39(1). 49–61. 48 indexed citations
14.
Gupta, Maya, Jahnavi Aluri, Mukesh Desai, et al.. (2018). Clinical, Immunological, and Molecular Findings in Four Cases of B Cell Expansion With NF-κB and T Cell Anergy Disease for the First Time From India. Frontiers in Immunology. 9. 1049–1049. 19 indexed citations
15.
Santos, Cristiane N., et al.. (2018). Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects. Frontiers in Immunology. 9. 2172–2172. 16 indexed citations
16.
Bergerson, Jenna, Kristin A. Erickson, & Anne Marie Singh. (2017). Tr1 Cell Identification and Phenotype in Children with and without Food Allergy. Journal of Allergy and Clinical Immunology. 139(2). AB70–AB70. 2 indexed citations
17.
Bergerson, Jenna, et al.. (2011). A Child With Sudden Vision Loss in One Eye. Clinical Pediatrics. 50(11). 1071–1075.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026